Knowledge Center

Patent / Aug 04, 2022

Inhaled ivermectin

Authors:
  • Beatriz Fernandes
  • João Henriques
  • Eunice Costa
  • Venkatesh Naini
Source:
US 20220241307

The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Ìý

Also in the Knowledge Center

Related Content

ASD-HIPROS

ASD-HIPROS, ËÄÉ«AV’s Intelligent Proprietary Screening, is the most advanced and accurate tool to identify Amorphous Solid Dispersion formulations by Spray Drying with maximum performance and stability.

Page
Read more

Drug Substance Technologies

We constantly innovate to find better, more efficient ways of doing things.

Page
Read more

API

ËÄÉ«AV inhalation grade APIs bring unique controlled performance to your formulation.

Page
Read more